为糖尿病患者打电话:实用性,1型有效性-实施混合临床试验的协议
Danila Cristina Paquier Sala1, Paula Cristina Pereira Costa2, Ana A Baumann3
1Universidade Federal de São Paulo, Escola Paulista de Enfermagem. São Paulo, São Paulo, Brasil.
Revista gaucha de enfermagem
|December 19, 2024
概括
本研究方案概述了一种基于电话的2型糖尿病自我护理干预措施,评估其有效性和在初级保健机构的实施.
科学领域:
- 糖尿病管理 糖尿病管理
- 初级医疗保健是一项主要的医疗保健.
- 实施科学 实施科学
背景情况:
- 2型糖尿病需要持续的自我照顾行为.
- 教育干预可以改善自我管理.
- 初级保健机构对于糖尿病支持至关重要.
研究的目的:
- 描述一个基于电话的干预的实施研究协议.
- 为了评估护士主导的电话对自我护理行为的有效性.
- 探索初级保健中的实施决定因素和结果.
主要方法:
- 混合型1有效性-实施实用随机临床试验.
- 198名2型糖尿病患者接受胰岛素治疗.
- 干预组接受护士带领的电话在ADCES7自我护理行为TM;对照组接受标准护理.
主要成果:
- 研究方案旨在评估血糖水平的变化和自我护理的遵守.
- 将使用COM-B模型评估实施决定因素.
- 将评估干预的可行性,可接受性和适当性.
结论:
- 本研究方案为评估一种针对2型糖尿病的新型电话干预措施提供了框架.
- 它旨在产生关于初级保健有效性和实施的证据.
- 结果可以为扩大糖尿病护理护理咨询提供信息.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Diabetes: Management and Pharmacotherapy
234
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
234
Insulin: Dosing Regimen and Adverse Effects
142
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
142
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K


